Patent · US Active

Treatment of cognitive disorders associated with abnormal dendritic spines using PKC activators

US9597312B2 · kind B2 · utility

1Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 19, 2011
Grant dateMar 21, 2017
Priority date—
Expiry dateFeb 24, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides methods of treating a cognitive disorder associated with abnormal dendritic spines, such as Fragile X Syndrome, Fragile X Associated Tremor/Ataxia Syndrome, autism, or mental retardation, using PKC activators.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.